PharmaSmart partners with McKesson on patient management solution
ROCHESTER, N.Y. — PharmaSmart International, a leading manufacturer of validated health screening kiosks and cloud-based health management solutions, has partnered with McKesson Pharmacy Systems to deliver a new, integrated solution for outcome-based patient management, the company announced Monday.
The integration brings together PharmaSmart’s clinical-grade, public-use health kiosk solutions with McKesson’s new Clinical Programs Solution, a product that helps retail pharmacies manage clinical programs directly within their pharmacy management system. CPS synchronizes PharmaSmart patient data with McKesson’s EnterpriseRx pharmacy management system.
“Our clients are looking for tools that enable their pharmacy teams to practice clinical care to the full extent of their license, while at the same time driving new clinical revenue and sustaining workflow efficiency," stated Josh Sarkis, PharmaSmart SVP strategic business development. "Our integrated solution with McKesson’s CPS platform accomplishes all three.”
“With today’s healthcare system moving towards a value-based reimbursement approach, integrated technology like McKesson’s Clinical Programs Solution, and specialized vendor integrations such as PharmaSmart, become more essential,” said Bernie Reese, SVP and general manager, McKesson Pharmacy Systems. “By leveraging new technologies to execute clinical services at a high level, community retail pharmacies can carve out new, sustained revenue streams, and become key stakeholders in value-based healthcare models.”
CDC tracks sharp uptick in flu
ATLANTA — The Centers for Disease Control and Prevention tracked a significant increase in the proportion of outpatient visits for influenza-like illness for the week ended Feb. 4.
ILI nationwide reached 4.8%, well above the national baseline of 2.2% and a sharp uptick in the 3.9% in ILI reported the week prior. All 10 regions reported ILI at or above their region-specific baseline levels, with New York City and 23 states experiencing high ILI activity and 10 states experiencing moderate ILI activity.
That's a measure of the severity of influenza activity. Geographically, influenza is also significantly widesepread. Outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in at least half the regions of the state with recent laboratory evidence of influenza in the state is defined as "widespread."
For the week ended Feb. 4, widespread influenza activity was reported by Puerto Rico and 43 states.
Relevo Labs introduces Touch Germ Blocker
CARMEL, Ind. — Relevo Labs recently introduced a new hand sanitizer that promises to protect against germs for up to six hours after application called Touch Germ Block.
People don’t apply sun block after they’ve been sunburned, Relevo Labs noted, and so too people shouldn’t apply hand sanitizer after they’ve encountered germs. The Touch Germ Block formula, which is alcohol-free, has improves upon the standard hand sanatizer in three key ways, according to the company.
First, traditional hand sanitizers are no longer effective once they dry, which means they need to be reapplied every time a user touches something, the company claims. Second, each application of Touch Germ Block softens and conditions hands with a special blend of essential oils and skin softeners. Finally, Touch Germ Block’s portable aerosol spray is easy to use and it distributes the product onto the surface of the skin more uniformly.
“Touch is revolutionary because it provides long-term protection unlike traditional hand sanitizers that protect against germs only during application and shortly after,” stated Brian Southard, CEO Relevo Labs. “Now, throughout the day, you can press elevator buttons or open doors and continually be protected from germs.”
Available in four fragrances, including oceanmist, tropical breeze, mint green tea aloe and unscented, Touch Germ Block retails for $5.99 and is currently available at Walgreens, CVS Pharmacy and Meijer.